Pipotiazine Palmitate

棕榈哌泊塞嗪

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePipotiazine Palmitate
Drug Alias NamePipothiazine Palmitate哌普嗪棕榈酸酯哌普嗪棕榈酸盐哌泊噻嗪棕榈酸酯安棕酯 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine receptors antagonists
TargetsDopamine receptors
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesTipr Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSchizophrenia
Inactive IndicationsN/A

Other Information

ATC CodeN05AC04
Related LinksWikipediaDrugBank